| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 11/03/2004 | CN1173974C Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist |
| 11/03/2004 | CN1173960C Substituted hexa azacylo compounds and their use as neuroregulator |
| 11/02/2004 | US6812344 1-(4-Arylpiperazin-1-yl)-ω-[N-(α,ω-dicarboximidoL)]-alkanes useful as uro-selective α1-adrenoceptor blockers |
| 11/02/2004 | US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 11/02/2004 | US6812236 Compounds useful in therapy |
| 11/02/2004 | US6812235 2-acylamino- beta -alanine derivatives and a pharmaceutically acceptable salt, useful as fibrinogen receptor antagonists |
| 11/02/2004 | US6812231 Inhibiting activated blood-coagulation factor x |
| 11/02/2004 | CA2094806C Aminosulfonyl urea acat inhibitors |
| 10/28/2004 | WO2004092164A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| 10/28/2004 | WO2004092146A2 N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes |
| 10/28/2004 | WO2004092137A1 Novel crystalline forms of donepezil hydrochloride |
| 10/28/2004 | WO2004092136A1 Nitrogenous heterocyclic compound and use thereof |
| 10/28/2004 | WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 10/28/2004 | WO2004092115A2 Hydroxamates as therapeutic agents |
| 10/28/2004 | WO2004092100A1 Indene derivatives as pharmaceutical agents |
| 10/28/2004 | WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 10/28/2004 | US20040215020 Process for preparing (+)trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine |
| 10/28/2004 | US20040215019 Substituted isoindoles and the e use thereof |
| 10/28/2004 | US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis |
| 10/28/2004 | US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal |
| 10/28/2004 | US20040214867 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals |
| 10/28/2004 | US20040214862 A N'-hydroxy-terephthalamide derivatives; histone deacetylase enzyme inhibitors; ANTIPROLIFERATIVE AGENTS; ANTITUMOR AGENTS |
| 10/28/2004 | US20040213816 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 10/28/2004 | CA2522084A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| 10/28/2004 | CA2522080A1 N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes |
| 10/28/2004 | CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 10/28/2004 | CA2521883A1 Indene derivatives as pharmaceutical agents |
| 10/27/2004 | EP1470108A1 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 10/27/2004 | EP1470102A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps) |
| 10/27/2004 | EP1469851A1 Melanocortin receptor agonists |
| 10/27/2004 | EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/27/2004 | EP0960108B1 Matrix metalloproteinase inhibitors |
| 10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 10/27/2004 | CN1541203A 4-(phenyl-(piperidin-4-YL)-amino)-benzamide derivatives and their use for treatment of pain, anxiety or gastrointestinal disorders |
| 10/27/2004 | CN1539824A Compounds with analygesic effect |
| 10/27/2004 | CN1172914C Gutarimide compound S632A3 and its prepn and application in preparing medicine for treating viral infection and tumor |
| 10/27/2004 | CN1172913C Levobubikain carbnoate and its preparation |
| 10/27/2004 | CN1172912C Racemistion process for use in manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents |
| 10/27/2004 | CN1172669C Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders |
| 10/26/2004 | US6809207 Amino acid derivatives |
| 10/26/2004 | US6809108 Selective muscarinic m3 receptor antagonts; reduced side effects |
| 10/26/2004 | US6809107 Neurodegenerative diseases |
| 10/26/2004 | US6809102 For therapy of proliferative diseases, such as cancer; to interrupt mitosis |
| 10/26/2004 | US6809093 Drug resistance therapy |
| 10/26/2004 | US6809083 Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections |
| 10/26/2004 | CA2261827C Use of amines to produce drugs for preventing tumour cell proliferation |
| 10/21/2004 | WO2004089933A1 Novel crystal of fluorobenzamide derivative |
| 10/21/2004 | WO2004089926A2 Genipin derivatives and uses thereof |
| 10/21/2004 | WO2004089922A2 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 10/21/2004 | WO2004089903A1 Piperidine derivatives as renin inhibitors for the treatment of hypertension |
| 10/21/2004 | WO2004089902A1 Process to prepare 1,4-dihydropyridine intermediates and derivatives thereof |
| 10/21/2004 | WO2004089901A2 Phospholipase c inhibitors for use in treating inflammatory disorders |
| 10/21/2004 | WO2004089377A1 Calcium channel blockers comprising two benzhydril moieties |
| 10/21/2004 | WO2004089373A1 4- (4-(heterocyclylalkoxy}phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer’s |
| 10/21/2004 | WO2004089370A1 4-phenyl-piperidine compounds and their use as modulators of opioid receptors |
| 10/21/2004 | WO2004089293A2 Hydroxamic acid compounds and methods of use thereof |
| 10/21/2004 | WO2004043369A3 Sulfonamides |
| 10/21/2004 | WO2004037181A3 Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods |
| 10/21/2004 | WO2003004025A8 High purity amlodipine benzenesulfonate and a process for its preparation |
| 10/21/2004 | US20040210061 Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol |
| 10/21/2004 | US20040210057 Process for obtainment of enantiomers of n-(2,6-dimethylphenyl) -1-propyl-2-piperidinocarboxamide process for obtainment of non-racemic mixtures between the enantiomers of n-(2,6-dimethylphenyl) -1-propyl-2- piperidinocarboxamide compound consisting of non-racemic mixtures of enantiomers of n-(2,6-dimethylphenyl) -1-propyl -2- piperidinocarboxamide pharmaceutical compositions consisting of non-racemic mixtures of enantiomers of n-(2,6-dimethylphenyl) -1-propyl -2-piperidiniocarboxamide |
| 10/21/2004 | US20040210056 Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines |
| 10/21/2004 | US20040210051 Inhibitors of binding between vascular cell adhesion molecules and cells expressing vla-4 integrin; antiinflammatory agents |
| 10/21/2004 | US20040209948 especially naphthalene sulfonamides, used for treating asthma |
| 10/21/2004 | US20040209926 asymmetrically-substituted xylylenediamines, e.g., N-(3-aminopropyl)-xylylenediamine; cancer, mucositis, asthma, inflammation, autoimmune disease, psoriasis, restentosis, rheumatoid arthritis, scleroderma, lupus, diabetes, tissue transplantation, osteoporosis, hyperparathyroidism, peptic ulcers, glaucoma |
| 10/21/2004 | US20040209915 substituted with an N- (p-hydroxy-alpha-hydroxybenzylaminoalkylpiperidinyloxy- (or -amino-)carbonylamino group; useful for identifying compounds having both beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 10/21/2004 | US20040209914 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 10/21/2004 | US20040209879 Piperidinyl derivates as modulators of chemokine receptor activity |
| 10/21/2004 | US20040209873 Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals |
| 10/21/2004 | US20040209872 Calcium channel blockers comprising two benzhydril moieties |
| 10/21/2004 | US20040209860 compounds having a (biphenyl-2-yl)oxycarbonylamino- or (biphenyl-2-yl)aminocarbonylamino-substituted (2-7C)azacycloalkyl or (5-10C)azabicycloalkyl group; and a 2-(4-hydroxyphenyl)-2-hydroxyethylamino group; treating asthma or chronic obstructive pulmonary disease; providing bronchodilation |
| 10/21/2004 | US20040209846 Heterocyclic analgesic compounds and methods of use thereof |
| 10/21/2004 | CA2522214A1 4-phenyl-piperidine compounds and their use as modulators of opioid receptors |
| 10/21/2004 | CA2521899A1 4- (4-(heterocyclylalkoxy}phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases suchas alzheimer's |
| 10/21/2004 | CA2521875A1 Calcium channel blockers comprising two benzhydril moieties |
| 10/21/2004 | CA2521433A1 Piperidine derivatives as renin |
| 10/21/2004 | CA2520611A1 Hydroxamic acid compounds and methods of use thereof |
| 10/21/2004 | CA2519882A1 Novel crystals of fluorobenzamide derivative |
| 10/20/2004 | EP1468999A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 10/20/2004 | EP1468994A1 Process for preparing cyclic amine substituted phenyl-alkyl-ketones |
| 10/20/2004 | EP1468684A1 Sigma receptor binder containing indanone derivative |
| 10/20/2004 | EP1467989A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection |
| 10/20/2004 | EP1467986A1 Aza-cyclic compounds as modulators of acetylcholine receptors |
| 10/20/2004 | EP1467984A2 Synthesis of 4,5-dihydro-pyrazolo (3,4-c) pyrid-2-ones |
| 10/20/2004 | EP1467723A1 Phenyl sulfoxides and phenyl sulfones |
| 10/20/2004 | EP1289964B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 10/20/2004 | EP1263725B1 Novel compounds |
| 10/20/2004 | EP1206507B1 Inhibition of polymerization of ethylenically unsaturated monomers |
| 10/20/2004 | EP1131291B1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
| 10/20/2004 | CN1538958A Solvates of lercanidipine hydro chloride and new crystalline forms of lercanidipine hydrochloride |
| 10/20/2004 | CN1538957A Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation |
| 10/20/2004 | CN1538951A Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells |
| 10/20/2004 | CN1538845A Phenyl derivatives as factor Xa inhibitors |
| 10/20/2004 | CN1171886C Process for producing carbostyril derivative |
| 10/20/2004 | CN1171871C 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators |
| 10/20/2004 | CN1171870C Inhibitors of cysteine protease |
| 10/20/2004 | CN1171866C Aryloxyarylsulfonylamino hydroxamic acid derivatives |
| 10/19/2004 | US6806378 Catalyst system and a process for the preparation of a nonracemic chiral alcohol by hydrogenation of a ketone using the catalyst system, wherein the catalyst system comprises ruthenium, a nonracemic chiral diphosphine ligand, an |
| 10/19/2004 | US6806365 N-alkanoylphenylalamine derivatives |
| 10/19/2004 | US6806281 Treatment of cocaine abuse, parkinson's disease |